<DOC>
	<DOCNO>NCT02383121</DOCNO>
	<brief_summary>Acute ischemic stroke ( AIS ) affect 700,000 Americans every year lead cause long-term disability . Early neurological deterioration AIS typically occur within 72 hour stroke onset affect 30 % stroke patient , high rate death poor outcome . Several mechanism account early neurological deterioration , include hemorrhagic conversion , systemic illness , cerebral edema , seizure , common cause extension stroke `` penumbra , '' region salvageable brain tissue surround core irreversible ischemic infarct . The penumbra tenuously perfuse collateral blood vessel . AIS management primarily focus recanalizing occlude artery cause stroke , alternative relatively unexplored approach optimization collateral blood flow . Over 60 % AIS patient present transient acute hypertensive response , theorize result either increase sympathoadrenal tone , poorly control underlying hypertension , unknown stroke-specific mechanism relate augment cerebral perfusion collateral blood flow . Epidemiological data suggest bad stroke outcomes associate extreme sustain hypo- hypertension , lead dozen clinical trial involve 20,000 patient determine pharmacologically lower blood pressure AIS beneficial . The result persistently neutral negative . In contrast , major clinical trial efficacy use vasopressor medication maintain increase baseline blood pressure AIS , despite promising preclinical data pilot study show increase cerebral hemorrhage edema . The randomized trial vasopressor use AIS demonstrate improvement clinical outcome , difference mean blood pressure control intervention arm , suggest beneficial effect exclusively relate induced hypertension . One possibility vasopressor reduce blood pressure variability , preliminary data show detrimental AIS , although aspect neurovascular couple adequately study acute phase AIS . The reliance IV vasopressor , administer intensive care unit , fundamental limitation prior research . An alternative , untested , approach use oral vasopressor midodrine hydrochloride . We hypothesize frequent midodrine dose AIS optimize collateral blood flow help salvage ischemic penumbra . The objective study develop tool quantify midodrine 's effect blood pressure ischemic penumbra . To achieve objective within period early neurologic deterioration , propose 72-hour protocol fixed-dose midodrine administration 20 AIS patient , detailed hemodynamic cerebral perfusion measurement record treatment period .</brief_summary>
	<brief_title>Midodrine Ischemic Stroke With Penumbra</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>1 . Adult patient , ≥ 18 year old , anterior circulation acute ischemic stroke diffusionweighted imaging ( DWI ) MRI , define predominant stroke burden frontal , parietal , temporal lobe . 2 . Demonstrable neurologic deficit due stroke randomization . 3 . Within 12 hour randomization , measure CT MR perfusion : cerebral blood flow ( CBF ) /DWI ratio ≥1.25 , absolute difference CBF DWI lesion ≥15 mL , DWI volume 20100 mL . ( Quantified Olea software ) 4 . Enrollment within 24 hour stroke onset 1 . Endovascular therapy intravenous tPA treatment stroke 2 . Acute myocardial infarction ECG troponin T &gt; 0.01 ng/mL . 3 . History cardiac disease , include myocardial infarction unstable angina within last 3 month , history clinically significant arrhythmia , symptomatic valvular disease , dilate cardiomyopathy , hypertrophic obstructive cardiomyopathy , leftventricular assist device , know ejection fraction &lt; 25 % . 4 . Glomerular filtration rate &lt; 50 , serum creatinine &gt; 1.5 mg/dl , severe urinary retention , endstage renal disease dialysis . 5 . Coagulopathy , include INR &gt; 1.5 , PTT &gt; 40 , platelet count &lt; 75 , use novel anticoagulant last 3 day ( e.g . dabigatran , rivaroxaban , apixaban ) . 6 . Positive pregnancy test . 7 . Clinical laboratory evidence thyrotoxicosis . 8 . Severe Peripheral Vascular Disease Raynaud 's syndrome . 9 . Systolic blood pressure ( SBP ) &gt; 180 diastolic blood pressure ( DBP ) &gt; 100 immediately prior randomization . 10 . Allergy history adverse reaction IV phenylephrine midodrine . 11 . Hemorrhage within area DWI lesion MRI . 12 . Indication anticoagulation within 5 day stroke onset . 13 . Arterial dissection cerebral aneurysm . 14 . Prestroke modify Rankin score &gt; 2 . 15 . Evidence bacterial endocarditis . 16 . Indication carotid endarterectomy stenting next 5 day . 17 . Inability unwillingness subject legal guardian/representative give write informed consent . 18 . Failure poststroke swallow evaluation alternative enteric access ( e.g . nasogastric feed tube , percutaneous endoscopic gastrostomy tube ) . 19 . Active drug alcohol use dependence , opinion site investigator , would interfere adherence study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>